![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: VPS13D |
Gene summary for VPS13D |
![]() |
Gene information | Species | Human | Gene symbol | VPS13D | Gene ID | 55187 |
Gene name | vacuolar protein sorting 13 homolog D | |
Gene Alias | SCAR4 | |
Cytomap | 1p36.22-p36.21 | |
Gene Type | protein-coding | GO ID | GO:0000422 | UniProtAcc | Q5THJ4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55187 | VPS13D | CCI_1 | Human | Cervix | CC | 1.79e-08 | 1.46e+00 | 0.528 |
55187 | VPS13D | CCI_2 | Human | Cervix | CC | 2.47e-11 | 1.07e+00 | 0.5249 |
55187 | VPS13D | CCI_3 | Human | Cervix | CC | 1.99e-20 | 1.32e+00 | 0.516 |
55187 | VPS13D | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.02e-24 | -4.84e-01 | 0.0155 |
55187 | VPS13D | HTA11_347_2000001011 | Human | Colorectum | AD | 2.51e-05 | 5.16e-01 | -0.1954 |
55187 | VPS13D | HTA11_4255_2000001011 | Human | Colorectum | SER | 3.14e-02 | -3.66e-01 | 0.0446 |
55187 | VPS13D | HTA11_11156_2000001011 | Human | Colorectum | AD | 1.87e-02 | -8.10e-01 | 0.0397 |
55187 | VPS13D | HTA11_6818_2000001021 | Human | Colorectum | AD | 1.41e-03 | -4.97e-01 | 0.0588 |
55187 | VPS13D | HTA11_99999973899_84307 | Human | Colorectum | MSS | 9.25e-04 | -4.11e-01 | 0.2585 |
55187 | VPS13D | HTA11_99999974143_84620 | Human | Colorectum | MSS | 5.68e-19 | -6.11e-01 | 0.3005 |
55187 | VPS13D | F007 | Human | Colorectum | FAP | 4.77e-09 | -4.50e-01 | 0.1176 |
55187 | VPS13D | A002-C-010 | Human | Colorectum | FAP | 1.81e-02 | -2.91e-01 | 0.242 |
55187 | VPS13D | A001-C-207 | Human | Colorectum | FAP | 4.47e-09 | -4.06e-01 | 0.1278 |
55187 | VPS13D | A015-C-203 | Human | Colorectum | FAP | 1.86e-35 | -5.44e-01 | -0.1294 |
55187 | VPS13D | A015-C-204 | Human | Colorectum | FAP | 3.34e-08 | -2.34e-01 | -0.0228 |
55187 | VPS13D | A014-C-040 | Human | Colorectum | FAP | 3.00e-06 | -3.10e-01 | -0.1184 |
55187 | VPS13D | A002-C-201 | Human | Colorectum | FAP | 3.80e-24 | -4.59e-01 | 0.0324 |
55187 | VPS13D | A002-C-203 | Human | Colorectum | FAP | 5.36e-05 | -2.81e-01 | 0.2786 |
55187 | VPS13D | A001-C-119 | Human | Colorectum | FAP | 2.76e-13 | -3.96e-01 | -0.1557 |
55187 | VPS13D | A001-C-108 | Human | Colorectum | FAP | 1.14e-16 | -2.72e-01 | -0.0272 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00725949 | Cervix | CC | establishment of protein localization to organelle | 99/2311 | 422/18723 | 1.23e-10 | 2.11e-08 | 99 |
GO:000989610 | Cervix | CC | positive regulation of catabolic process | 109/2311 | 492/18723 | 5.26e-10 | 6.99e-08 | 109 |
GO:00512359 | Cervix | CC | maintenance of location | 78/2311 | 327/18723 | 5.18e-09 | 4.92e-07 | 78 |
GO:005165110 | Cervix | CC | maintenance of location in cell | 55/2311 | 214/18723 | 6.63e-08 | 3.85e-06 | 55 |
GO:003133110 | Cervix | CC | positive regulation of cellular catabolic process | 91/2311 | 427/18723 | 9.64e-08 | 5.25e-06 | 91 |
GO:000660510 | Cervix | CC | protein targeting | 68/2311 | 314/18723 | 2.17e-06 | 6.55e-05 | 68 |
GO:00325077 | Cervix | CC | maintenance of protein location in cell | 21/2311 | 65/18723 | 2.03e-05 | 3.71e-04 | 21 |
GO:004518510 | Cervix | CC | maintenance of protein location | 26/2311 | 94/18723 | 4.85e-05 | 7.34e-04 | 26 |
GO:002241110 | Cervix | CC | cellular component disassembly | 83/2311 | 443/18723 | 6.04e-05 | 8.68e-04 | 83 |
GO:00726655 | Cervix | CC | protein localization to vacuole | 20/2311 | 67/18723 | 1.12e-04 | 1.40e-03 | 20 |
GO:00108218 | Cervix | CC | regulation of mitochondrion organization | 34/2311 | 144/18723 | 1.27e-04 | 1.58e-03 | 34 |
GO:00162367 | Cervix | CC | macroautophagy | 58/2311 | 291/18723 | 1.40e-04 | 1.70e-03 | 58 |
GO:00105067 | Cervix | CC | regulation of autophagy | 61/2311 | 317/18723 | 2.61e-04 | 2.87e-03 | 61 |
GO:00004227 | Cervix | CC | autophagy of mitochondrion | 21/2311 | 81/18723 | 6.47e-04 | 6.02e-03 | 21 |
GO:00617267 | Cervix | CC | mitochondrion disassembly | 21/2311 | 81/18723 | 6.47e-04 | 6.02e-03 | 21 |
GO:00070347 | Cervix | CC | vacuolar transport | 34/2311 | 157/18723 | 7.03e-04 | 6.40e-03 | 34 |
GO:00066235 | Cervix | CC | protein targeting to vacuole | 12/2311 | 37/18723 | 1.15e-03 | 9.39e-03 | 12 |
GO:00108224 | Cervix | CC | positive regulation of mitochondrion organization | 19/2311 | 74/18723 | 1.30e-03 | 1.03e-02 | 19 |
GO:00726665 | Cervix | CC | establishment of protein localization to vacuole | 14/2311 | 49/18723 | 1.84e-03 | 1.37e-02 | 14 |
GO:19031466 | Cervix | CC | regulation of autophagy of mitochondrion | 10/2311 | 33/18723 | 5.07e-03 | 3.00e-02 | 10 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
VPS13D | SNV | Missense_Mutation | c.2750N>G | p.Ile917Ser | p.I917S | Q5THJ4 | protein_coding | tolerated(0.18) | benign(0.373) | TCGA-B7-5818-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
VPS13D | SNV | Missense_Mutation | c.6931G>A | p.Ala2311Thr | p.A2311T | Q5THJ4 | protein_coding | tolerated(0.07) | probably_damaging(0.993) | TCGA-BR-4256-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
VPS13D | SNV | Missense_Mutation | c.1817N>A | p.Gly606Asp | p.G606D | Q5THJ4 | protein_coding | tolerated(0.65) | benign(0) | TCGA-BR-6852-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
VPS13D | SNV | Missense_Mutation | rs140358420 | c.6032N>T | p.Thr2011Met | p.T2011M | Q5THJ4 | protein_coding | tolerated(0.07) | benign(0.062) | TCGA-BR-8078-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
VPS13D | SNV | Missense_Mutation | rs764217378 | c.1475N>A | p.Arg492Gln | p.R492Q | Q5THJ4 | protein_coding | deleterious(0) | probably_damaging(0.992) | TCGA-BR-8487-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
VPS13D | SNV | Missense_Mutation | c.664N>G | p.Leu222Val | p.L222V | Q5THJ4 | protein_coding | tolerated(0.13) | benign(0.207) | TCGA-BR-8589-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
VPS13D | SNV | Missense_Mutation | c.4220N>C | p.Ile1407Thr | p.I1407T | Q5THJ4 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-BR-8591-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
VPS13D | SNV | Missense_Mutation | c.1930N>C | p.Lys644Gln | p.K644Q | Q5THJ4 | protein_coding | tolerated(0.19) | probably_damaging(0.923) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR | |
VPS13D | SNV | Missense_Mutation | c.4090N>T | p.Asp1364Tyr | p.D1364Y | Q5THJ4 | protein_coding | deleterious(0.03) | benign(0.194) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR | |
VPS13D | SNV | Missense_Mutation | c.8453N>T | p.Ser2818Leu | p.S2818L | Q5THJ4 | protein_coding | deleterious(0.03) | possibly_damaging(0.58) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |